Concord Biotech Limited (NSE:CONCORDBIO)
India · Delayed Price · Currency is INR 1,197.20
+21.90 (1.86%)
Mar 10, 2026, 3:30 PM IST
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 122.96 billion as of March 10, 2026. Its market cap has decreased by -30.55% in one year.
Market Cap
122.96B
Enterprise Value
119.65B
Revenue
11.59B
Ranking
n/a
PE Ratio
39.59
Stock Price
1,197.20
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 122.96B, an increase of 24.66%. That is a compound annual growth rate of 9.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 122.96B | -12.66% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 632.30B |
| Anthem Biosciences | 372.46B |
| OneSource Specialty Pharma | 169.70B |
| Blue Jet Healthcare | 66.84B |
| Supriya Lifescience | 50.54B |
| Zota Health Care | 40.47B |
| Dishman Carbogen Amcis | 25.75B |
| Panacea Biotec | 19.63B |